We and other groups reported that NHERF1 could form signaling complexes with PTEN or tyrosine kinase receptors including PDGFR and EGFR to counterbalance AKT and ERK signaling in breast cancer cells [7,11]. The gene discussed is NHERF1; the disease is breast carcinoma.